Medication Guide App

ULTRASE MT 20 (Ultrase MT 20 65,000 units amylase; 20,000 units lipase; 65,000 units protease)

Generic Name: pancrelipase

Pill imprint ULTRASE MT 20 has been identified as Ultrase MT 20 65,000 units amylase; 20,000 units lipase; 65,000 units protease.

Ultrase MT 20 is used in the treatment of chronic pancreatitis; pancreatic exocrine dysfunction; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy. Ultrase MT 20 65,000 units amylase; 20,000 units lipase; 65,000 units protease is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for ULTRASE MT 20

Ultrase MT 20 65,000 units amylase; 20,000 units lipase; 65,000 units protease ULTRASE MT 20
Ultrase MT 20 65,000 units amylase; 20,000 units lipase; 65,000 units protease ULTRASE MT 20
Ultrase MT 20
Generic Name:
pancrelipase
Imprint:
ULTRASE
MT 20
Strength:
65,000 units amylase; 20,000 units lipase; 65,000 units protease
Color:
Gray / Yellow
Shape:
Capsule-shape
Availability:
Rx and/or OTC
Drug Class:
Digestive enzymes
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Axcan Scandipharm Inc.
National Drug Code (NDC):
58914-0004

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)